Clinical Trial Update: Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating T-APCs after CAR T cell immunotherapy for CD19-positive acute leukemia is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CAR T cell immunotherapy (Chimeric antigen receptor T-cell therapy)
• T-APCs

Snippet

Sponsor: Seattle Children's Hospital | Conditions: CD 19+ Acute Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING